The Medical University of Pleven is seeking suppliers for the delivery of laboratory reagents, consumables, and kits as part of project BG-RRP 2.004-0003. The procurement is divided into several categories: 1) Nanopore sequencer, 2) DNA repair kits, 3) Medical devices for the pharmacognosy laborator
Tender closed on 10 Sept 2025. Awaiting award.
This contract involves the supply of medical consumables necessary for the execution of activities related to research program 3.1.10 from project BG-RRP-2.004-0004-C01: 'Strategic Research and Innovation Program for the Development of Medical University - Sofia', funded by the National Recovery and
This contract opportunity involves the supply of audio-visual equipment and technology for the First Auditorium of the Faculty of Dental Medicine and the Projection Room in the Medical-Biological Complex at the Medical Faculty of Sofia Medical University. The supplier will be responsible for the del
This contract involves the periodic delivery of reagents and medical consumables for closed systems as part of projects under the SMN and FNI at the Medical University of Sofia. The procurement is divided into 12 distinct lots. It is essential that all reagents and medical consumables from each lot
This public procurement contract is divided into 12 specific categories, detailing the required characteristics of the items according to the Technical Specification – Appendix No. 1 of the procurement documentation. The categories include: 1. Dental materials, tools, and supplies for the Dental Tec
Funding up to £3 million for human experimental medicine studies investigating the biological and psychological causes of gambling disorder development and recovery.
Apply for up to £26.25 million in MRC funding over 14 years to establish a centre of research excellence addressing complex health challenges.
Grants up to £200,000 available for early-stage, high-risk environmental research projects without requiring preliminary data, running for up to two years.
UKRI is funding empirical research to establish reliable estimates of the economic and social returns on R&D investments to guide public and private sector decision-making.
